XML 100 R83.htm IDEA: XBRL DOCUMENT v3.21.2
Stock-Based Compensation Plans - Schedule of Nonvested Stock Award Activity (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
12 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2019
Nonvested Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares      
Unvested shares, beginning balance (in shares) 1,668    
Granted (in shares) 520    
Expected performance adjustments (126)    
Vested (in shares) (288)    
Forfeitures (in shares) (58)    
Unvested shares, ending balance (in shares) 1,968 1,668  
Unvested shares ending balance, weighted average grant date fair value (usd per share) $ 21.50 $ 20.89  
Granted, weighted average grant date fair value (in usd per share) 22.33 $ 22.17 $ 20.72
Share-based Compensation Arrangement by Share Based Award, Equity Instruments Other Than Options Performance Shares weighted Average 22.96    
Vested, weighted average grant date fair value (in usd per share) 22.69    
Forfeitures, weighted average grant date fair value (in usd per share) $ 21.85    
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value      
Grant date fair values of shares vested $ 7 $ 5 $ 12
Unvested shares beginning balance, weighted average grant date fair value (usd per share) $ 20.89    
Nonvested Stock Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value      
Award vesting period 1 year    
Nonvested Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value      
Award vesting period 3 years    
Nonvested Stock Units - Performance Based      
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value      
Award vesting period 3 years    
Minimum risk free interest rate 0.13% 1.55% 2.66%
Maximum risk free interest rate 0.23% 1.59% 2.82%